普洛药业：产品“阿莫西林克拉维酸钾片”取得注册证

Company Overview - Prolog Pharma (SZ 000739, closing price: 16.18 CNY) announced on December 1 that its wholly-owned subsidiary, Zhejiang Prolog Jutai Pharmaceutical Co., Ltd., received a drug registration certificate for Amoxicillin and Clavulanate Potassium Tablets from the National Medical Products Administration [1] Financial Performance - For the first half of 2025, Prolog Pharma's revenue composition is as follows: 99.6% from the pharmaceutical industry and 0.4% from other businesses [1] - As of the report date, Prolog Pharma's market capitalization stands at 18.7 billion CNY [1]